Shukla, D. and Chandel, H.S. and Srivastava, S. and Chauhan, P. and Pandey, S.P. and Patidar, A. and Banerjee, R. and Chattopadhyay, D. and Saha, B. (2018) TLR11 or TLR12 silencing reduces Leishmania majorinfection. Cytokine, 104. pp. 110-113.

Pandey , S.P. and Doyen, N. and Mishra, G.C. and Saha, B. and Chandel, H.S. (2015) TLR9-deficiency reduces TLR1, TLR2 and TLR3 expressions in Leishmania major-infected macrophages. Experimental Parasitology, 154. pp. 82-86.

Pandey , S.P. and Chandel , H.S. and Srivastava , S. and Selvaraj , S. and Jha, M.K. and Shukla , D. and Ebensen , T. and Guzman , C.A. and Saha , B. (2014) Pegylated Bisacycloxypropylcysteine, a Diacylated Lipopeptide Ligand of TLR6, Plays a Host-Protective Role against Experimental Leishmania major Infection. Journal of Immunology , 193. pp. 3632-3643.

Srivastava , S. and Pandey , S.P. and Jha , M.K. and Chandel , H.S. and Saha , B. (2013) Leishmania expressed lipophosphoglycan interacts with Toll-like receptor (TLR)-2 to decrease TLR-9 expression and reduce anti-leishmanial responses. linical and Experimental Immunology, 172. pp. 403-409.